One company that should be on your radar is Acceleron Pharma, Inc. ( XLRN ). The stock of this biopharmaceutical company has seen its Zacks Rank surge over the past four weeks, moving from Neutral territory to its current position as a Buy.AFFYMETRIX INC (AFFX): Free Stock Analysis ReportACTELION LTD (ALIOF): Get Free ReportCORONADO BIOSCI (CNDO): Free Stock Analysis ReportACCELERON PHARM (XLRN): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research
A key reason for this move has been the positive trend in the earnings estimate revisions picture. For XLRN's full year estimate, we have seen 1 estimate go higher in the past 30 days, compared to none lower. This trend has helped the consensus estimate to trend higher, going from 18 cents a share a month ago to its current level at 25 cents.
This positive shift in estimates has made some investors take notice and buy the stock. In fact, XLRN has seen some pretty solid trading lately, as the company has moved higher by 38.9% in the past month.
If Acceleron can keep up this great momentum on the earnings estimate front and continue to impress analysts, we could see more gains ahead for this company, suggesting that you might want to put XLRN on your watch list for the future.
Other top-ranked stocks worth considering in this space include Actelion Ltd. ( ALIOF ), Affymetrix Inc. ( AFFX ), and Coronado Biosciences, Inc. ( CNDO ). All these carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>